BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3334561)

  • 1. Immunomodulating properties of newer cephalosporins: a preliminary classification.
    Labro M; Bryskier A
    Chemioterapia; 1987 Jun; 6(2 Suppl):219-21. PubMed ID: 3334561
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of ceftriaxone on bacterial killing by human neutrophils in vitro.
    Labro M; Babin-Chevaye C; Pochet I; Hakim J
    Chemioterapia; 1987 Jun; 6(2 Suppl):234-6. PubMed ID: 3334563
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of cefotaxime versus desacetyl cefotaxime on human neutrophil functions.
    Labro M; Bryskier A
    Chemioterapia; 1987 Jun; 6(2 Suppl):237-9. PubMed ID: 3334564
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of ceftriaxone with human polymorphonuclear neutrophil function.
    Labro MT; Babin-Chevaye C; Pochet I; Hakim J
    J Antimicrob Chemother; 1987 Dec; 20(6):849-55. PubMed ID: 2831183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal disk susceptibility testing of Staphylococcus epidermidis and aureus against penicillinase-resistant semisynthetic penicillins and cephalosporins.
    Wybo I; Pierard D; Lauwers S
    J Chemother; 1989 Jul; 1(4 Suppl):324-5. PubMed ID: 16312422
    [No Abstract]   [Full Text] [Related]  

  • 6. [New cephalosporin antibiotic: cephapirin].
    Urbinati G
    Clin Ter; 1977 Mar; 80(5):491-9. PubMed ID: 322931
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro bactericidal action of cephalosporins in different concentrations of serum.
    Magliulo E; Ceccarelli G; Bianchi PP; Piantieri G; Cafarelli A
    G Batteriol Virol Immunol; 1981; 74(1-6):39-47. PubMed ID: 6458527
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of the variations in inoculum on the cephalosporins' in vitro antibacterial activity.
    Cafarelli A; Magliulo E; Piantieri G
    G Batteriol Virol Immunol; 1981; 74(1-6):26-38. PubMed ID: 6458525
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of cefpodoxime on selected immunological functions and bacterial pathogenicity factors in vitro.
    Schubert S; Ullmann U
    Zentralbl Bakteriol; 1991 Jun; 275(2):233-40. PubMed ID: 1930575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced susceptibility of Staphylococcus aureus pretreated with cefepime and cefpodoxime to leukocyte activity.
    Herrera I; Martinez P; Perez P; Garcia Y; Gomez-Lus ML; Prieto J
    J Chemother; 1995 Nov; 7 Suppl 4():23-5. PubMed ID: 8904094
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro bactericidal action of cefoperazone, cefoxitin, cefuroxime, cefazolin and cephaloridine.
    Piantieri G; Cafarelli A; Magliulo E
    G Batteriol Virol Immunol; 1981; 74(1-6):15-25. PubMed ID: 6458524
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunomodulation of polymorphonuclear leukocytes by D53 Immucytal and its constitutive fractions.
    Minonzio F; Ongari AM; Venegoni E; Carbonelli V; Licciardello L; Capsoni F
    Boll Ist Sieroter Milan; 1989; 68(3):241-8. PubMed ID: 2491432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro effects of ceftibuten on the host defense mechanism.
    Braga PC; Piatti G; Dal Sasso M; Maci S; Blasi F
    Chemotherapy; 1994; 40(1):37-41. PubMed ID: 8306814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in microbial structure and function induced by exposure to antimicrobial agents: implications for host response to infection.
    Gemmell CG
    Chemioterapia; 1987 Jun; 6(2 Suppl):211-2. PubMed ID: 3509389
    [No Abstract]   [Full Text] [Related]  

  • 15. Decrease in surface charge density of Klebsiella pneumoniae treated with cefodizime and enhancement of the phagocytic function of human polymorphonuclear leucocytes stimulated by the drug-treated bacteria.
    Muratsugu M; Miyake Y; Ishida N; Hyodo A; Terayama K
    Biol Pharm Bull; 1995 Sep; 18(9):1259-63. PubMed ID: 8845818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial symposium. Part IV. Cephalosporins.
    Cooper TW; Gibbs WJ; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2006 Dec; 99(12):579-83. PubMed ID: 17310925
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluoroquinolone derivatives: effects on neutrophil functional tests.
    Bersani C; Santagada T; Bertoletti R; Fietta A; Gialdroni Grassi G
    Chemioterapia; 1987 Jun; 6(2 Suppl):222-3. PubMed ID: 3334562
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative plasma bactericidal activity of cephapirin and cefazolin.
    Hottendorf GH; Price KE; Van Harken DR
    Curr Ther Res Clin Exp; 1975 Aug; 18(2):364-70. PubMed ID: 809250
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergistic effect of cefepime on the phagocytic killing of Staphylococcus aureus by human polymorphonuclear leucocytes and the determination of this effect by means of nitrite production.
    Sultan N; Cirak MY; Erbaş D
    Microbios; 2000; 103(405):97-106. PubMed ID: 11092191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefmetazole: a broad spectrum cephem antibiotic effective on methicillin- and cephem-resistant Staphylococcus aureus.
    Yokota T; Yoshida R; Utsui Y; Tajima M
    Drugs Exp Clin Res; 1985; 11(1):29-38. PubMed ID: 3915273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.